1 / 22

Physiological Role and Molecular Mechanism of Adiponectin

Physiological Role and Molecular Mechanism of Adiponectin. Yumi Ando Pomona College Advanced Biochemistry. What is Adiponectin??. A signaling molecule that is secreted from white and brown adipose tissue. Composed of 247 amino acids. Accounts for 0.05 % of total serum protein.

Download Presentation

Physiological Role and Molecular Mechanism of Adiponectin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Physiological Role and Molecular Mechanism of Adiponectin Yumi Ando Pomona College Advanced Biochemistry

  2. What is Adiponectin?? • A signaling molecule that is secreted from white and brown adipose tissue. • Composed of 247 amino acids. • Accounts for 0.05 % of total serum protein. • Concentration: 2~20 μg/mL in the blood

  3. Aside: Adipose Tissue • Adipose tissue stores & releases energy in the form of TAG and free fatty acids, respectively. • HOWEVER, it is also gaining recognition as an endocrine organ that secretes proteins w/ pro-inflammatory effects, as well as metabolic effects. • These proteins are called “adipocytokines” or “adipokines” • Examples: adiponectin, leptin, resistin.

  4. Structure of adiponectin • 3 domains: Collagen-like domain, globular domain, and a signal sequence. Taken from Kadowaki and Yamauchi, 2004

  5. Form homomultimers • 3 main oligomeric forms: LMW, MMW, and HMW • Oligomerization of adiponectin depends on disulphide bonds formed by Cys39 Taken from Kadowaki and Yamauchi, 2005

  6. Two forms, two different functions? • Adiponectin can exist as a full-length protein or as a globular form by undergoing proteolytic cleavage, which leaves only the globular head domain intact. • The globular form of adiponectin appears to stimulate β oxidation in muscle, while the full-length form appears to decrease glucose output by the liver

  7. Genetic Factors • The gene for adiponectin is located on chromosome 3q27. • This region of the chromosome has also been linked to type 2 diabetes. • A SNP located 276 base pairs downstream of the start site of the adiponectin gene was associated with increased insulin resistance and risk of developing type 2 diabetes.

  8. Why is it important to study adiponectin? • Evidence strongly suggests that adiponectin plays a role in the pathophysiology of type 2 diabetes and other metabolic syndrome diseases!!

  9. Correlation between adiponectin and insulin resistance • Obesity and type 2 diabetes are associated with decreased adiponectin levels • Reduced plasma adiponectin is also seen in people with conditions such as cardiovascular disease and hypertension, diseases that are often associated with insulin resistance.

  10. In a study conducted by Hotta et al., (2001), plasma adiponectin levels dropped in parallel to the observation of decreased insulin sensitivity in rhesus monkeys. • Monkeys w/ decreased insulin sensitivity developed type 2 diabetes.

  11. Molecular Mechanism of Adiponectin • A study conducted by Yamauchi et al. (2001) showed that adiponectin stimulates glucose utilization and fatty acid oxidation by activating AMP-activated protein kinase.

  12. Adiponectin Receptors • There are two known ones: AdipoR1 and AdipoR2. • They are integral membrane proteins that have seven transmembrane domains where the N terminus is located within the cell, and the C terminus is external. • AdipoR1 is a receptor that mainly binds globular adiponectin, while AdipoR2 binds to full-length adiponectin • AdipoR1 is abundant in skeletal muscle. On the other hand, AdipoR2 is most expressed in the liver.

  13. Possible therapeutic strategies… • 3 methods have been studied. • Upregulation of adiponectin • Upregulation of adiponectin receptors • Development of adiponectin receptor agonists

  14. Osmotin • potential agonist for adiponectin!! • It is a plant protein that is implicated in the plant defense system. Causes apoptosis in yeast. • adiponectin and osmotin were able to induce phosphorylation of AMP kinase in C2C12 myocytes.

  15. 5 things to remember… • adiponectin is a potent insulin sensitizing molecule. • The two forms (globular and full-length) bind to different receptors and have different effects. • Decreased levels of adiponectin induced by genetic mutations, obesity, and high fat diets lead to insulin resistance and pathological conditions such as type 2 diabetes. • Adiponectin activates signaling cascades that eventually increase glucose uptake by muslce, increase fatty acid oxidation by muscle and liver, and decrease gluconeogenesis in the liver. • In the future, Osmotin could be used as a novel therapeutic method for hypoadiponectinemia.

  16. References • Cnop M. et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 46: 459–469. • Fasshauer M., Paschke R., and Stumvoll, M. (2004) Adiponectin, obesity, and cardiovascular disease. Biochimie. 86: 779-784. • Lihn A.S., Pedersen S.B., and Richelsen B. (2004) Adiponectin: action, regulation, and association to insulin sensitivity. Obesity Reviews. 6: 13-21. • Fruebis J. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 98: 2005-2010. • Hara K., et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 51:536–540. • Hotta K., et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 50:1126–1133 • Kadowaki T., and Yamauchi T. (2005) Adiponectin and Adiponectin Receptors. Endocrine Reviews. 26(3): 439-451. • Kadowaki T. et al.(2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation. 116(7): 1784-1792. • Kubota N., et al. (2006) Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and adiponectin-independent pathways. J. Biol. Chem. 281(13): 8748-8755. • Narasimhan M.L. et al. (2005) Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptors. Molecular Cell. 17(2): 171-180. • Qi Y. et al. (2004) Adiponectin acts in the brain to decrease body weight. Nature Medicine. 10: 524-529. • Shapiro L. and Scherer, P.E. (1998) The crystal structure of complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology. 8: 335-338. • Yamauchi T., et al. (2001) The fat-derived horomone adiponectin reverses insulin resistance associated ith both lipoatrophy and obesity. Nature. 7(8): 941-946. • Yamauchi T., et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 8(11): 1288-1295. • Yamauchi et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423:762-769.

More Related